Top 10 International Stocks To Buy For 2014

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Orthofix International (NASDAQ: OFIX  ) , a medical device company specializing in spinal and orthopedic applications, shed as much as 21% of their value after the company reported its first-quarter results and received four analyst downgrades.

So what: For the quarter, Orthofix saw sales drop 14% to $100.3 million from the year-ago period as EPS declined by 66% to just $0.23. Its spine segment delivered a sales decline of 12% compared to a 17% decline from its orthopedics division with both experiencing significant weakness from international markets (e.g., Europe and Brazil). The Street had been expecting a profit of $0.66 per share on revenue of roughly $111 million in sales, so its results weren't even in the ballpark. Orthofix did authorize a $50 million share repurchase program, but that hardly made a dent with Mizuho, JMP Securities, Janney Capital, and Lazard Capital�all downgrading the company. Looking ahead, Orthofix is forecasting second-quarter revenue of $104 million to $107 million, which is well below the $119.7 million that the Street had been projecting.

Hot Financial Companies To Invest In 2015: Live Nation Entertainment Inc. (LYV)

Live Nation Entertainment, Inc. operates as a live entertainment company. The company operates through Concerts, Ticketing, Artist Nation, and Sponsorship & Advertising segments. The Concerts segment engages in the promotion of live music events in its owned and/or operated venues, and in rented third-party venues; operation and management of music venues; and production of music festivals. The Ticketing segment operates an agency business that sells tickets for its events and third-party clients across various live event categories through its Websites, telephone services, and ticket outlets. This segment provides ticketing services for arenas, stadiums, amphitheaters, music clubs, concert promoters, professional sports franchises and leagues, college sports teams, performing arts venues, museums, and theaters. The Artist Nation segment offers management services to music artists; sells merchandise associated with musical artists at live performances to retailers and dire ctly to consumers through the Internet; and provides other services to artists. The Sponsorship & Advertising segment offers online advertising services; and online sponsorship programs for corporate clients. As of December 31, 2012, the company owned, operated, or leased 93 entertainment venues and 100 other facilities in North America; and 22 entertainment venues and 82 other facilities internationally. The company was formerly known as Live Nation, Inc. and changed its name to Live Nation Entertainment, Inc. in January 2010. Live Nation Entertainment, Inc. was incorporated in 2005 and is headquartered in Beverly Hills, California.

Advisors' Opinion:

• [By Bloomberg]

  To spark a bidding contest for World Wrestling Entertainment Inc. (WWE), all Vince McMahon needs to do is wave a "for sale" sign. McMahon, 68, controls the voting power of the $2.3 billion company that's been entertaining spectators with staged fights for decades. The stock is at a record after WWE launched its own subscription streaming network and became the subject of takeover speculation. Should McMahon ever decide he's ready to sell, companies from Comcast Corp. (CMCSA) to Madison Square Garden Co. (MSG) may line up with offers, Albert Fried & Co. and National Alliance Capital Markets said. "What is McMahon's succession plan and who will he pass the keys of the kingdom to?" Robert Routh, an analyst at National Alliance, said in a phone interview. "WWE would be very attractive to many different types of buyers. What they've built can't be recreated. But without McMahon's blessing, it doesn't matter how much somebody is willing to pay for the company." The franchise that thrust Hulk Hogan and The Rock into stardom owns the television shows "Raw" and "Smackdown," which have a dedicated following and command high cable-TV ratings, Vertical Group said. The company, which is hosting its annual WrestleMania event in three weeks, will post its best revenue and profit growth in more than a decade next year, according to analysts' estimates compiled by Bloomberg. Stock Surge The stock has climbed 35 percent this month, in part because of takeover speculation, to close at $30.94 last week. WWE isn't in merger talks, Chief Financial Officer George Barrios said in an interview March 6. A representative for the Stamford, Connecticut-based company, declined to comment last week beyond Barrios' earlier statement. WWE's programs, which air on Comcast's USA and SyFy cable networks, may find a new home by the end of April, Barrios said. He said the company is in discussions on future domestic TV distribution with "multiple parties." It has held distribution tal

• [By WWW.DAILYFINANCE.COM]

  Michael Tullberg/Getty Images Los Angeles County's fabled Sunset Strip -- home to numerous legendary nightclubs -- is going corporate. Goodbye, Rat Pack and Guns N' Roses; hello, Marriott International (MAR). Gangsters and Guitarists Through a quirk of urban planning, the Strip -- a 1.6-mile stretch of Sunset Boulevard -- was part of unincorporated land within Los Angeles city limits (these days, it belongs to the micro-city of West Hollywood). As such, it was overseen not by the L.A. Police Department, but by the more lax County Sheriff's department. Entrepreneurs took advantage of this, and in the early 20th century the Strip soon became the hottest entertainment destination in the L.A. area, home to clubs, bars and the occasional house of ill repute. In the 1940s and 1950s its nightclubs frequently hosted the top stars of the era. Many a band across the subsequent decades rose to prominence playing joints like The Roxy, Whisky A Go Go (still going strong at 50), and the Viper Room. Throughout the world, the Strip was nearly synonymous with nightlife. So much so that, according to some, its name was cribbed by the burgeoning city of Las Vegas to title the strategic section of its main thoroughfare. For many years now, the heart of Las Vegas Boulevard has been known simply as "The Strip." The City That Sometimes Sleeps The Strip is not the only game in town for visitors. Close by is the gay mecca of West Hollywood's "Boy's Town" neighborhood, while the tiny city's location in the kernel of L.A. makes it the perfect springboard for visiting Hollywood, L.A.'s beaches, and the neighboring Beverly Hills. Tourism is big business for West Hollywood. Twenty percent of the municipality's fiscal 2013 take came from the transient occupancy (i.e., lodging) taxes levied on those visitors. This brought in a cool $18 million that year -- 18 percent higher year over year, by the way -- making it WeHo's No. 2 revenue source. And there's more where that came from. Las

• [By Lisa Levin]

  Breaking news

  Weyerhaeuser Co (NYSE: WY) reported a 34% rise in its third-quarter profit. Weyerhaeuser's quarterly profit surged to $157 million, or $0.27 per share, from $117 million, or $0.22 per share, in the year-ago period. To read the full news, click here. Sorrento Therapeutics (NASDAQ: SRNE) announced the pricing of an underwritten public offering of 4,150,000 shares of common stock at an offering price of $7.25 per share. To read the full news, click here. Live Nation Entertainment (NYSE: LYV) has acquired Voodoo Music & Arts Experience, New Orleans' critically-acclaimed music festival. To read the full news, click here. B/E Aerospace (NASDAQ: BEAV) today announced that its Board of Directors has appointed Werner Lieberherr, who is currently President and Chief Operating Officer of B/E Aerospace, Inc., as co-Chief Executive Officer of B/E Aerospace, Inc. effective as of January 1, 2014. To read the full news, click here.

  Posted-In: JP Morgan US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Top 10 International Stocks To Buy For 2014: Brookfield Infrastructure Partners LP (BIP)

Brookfield Infrastructure Partners L.P. engages in the utilities, transportation and energy, and timber businesses. It operates through Utilities, Transport, Energy, and Timber segments. The company operates a port facility that exports metallurgical and thermal coal mined in the central Bowen Basin region of Queensland, Australia; approximately 9,900 kilometers of electricity transmission lines in North and South America; and approximately 2.5 million electricity and natural gas connections in the United Kingdom, New Zealand, and Colombia. It is also involved in the transportation of freight, bulk commodities, and passengers through a platform of approximately 5,100 kilometers of tracks in southwest region of Western Australia; 3,200 kilometres of toll roads in Brazil and Chile; and approximately 30 port terminals primarily in Europe. In addition, the company provides energy transportation, distribution, and storage services through 15,500 kilometers of natural gas transm ission lines primarily in the United States. Further, it engages in the timberland operations with approximately 343,000 net acres of freehold timberlands located in the coastal region of British Columbia, Canada; and the Pacific Northwest region of the United States. Brookfield Infrastructure Partners Limited serves as a general partner of Brookfield Infrastructure Partners L.P. The company was founded in 2007 and is based in Toronto, Canada. Brookfield Infrastructure Partners L.P. is a subsidiary of Brookfield Asset Management Inc.

Advisors' Opinion:

• [By Federico Zaldua]

  I expect the Brookfield Group of Companies, which is composed of no fewer than 15 publicly traded entities, to be very active acquisitive in the near-term future. Here I focus my attention on three members of the Brookfield Group that are going to be the most active with M&A. While Brookfield Asset Management (BAM) will concentrate its M&A efforts into all geographies and all asset classes, Brookfield Renewable Energy Partners (BEP) and Brookfield Infrastructure Partners (BIP) will concentrate on their respective industries. Let's see whether you should go long on any of this separate -although related - entities.
  
  Good Operational Performance
  
  Brookfield Asset Management, held by Lou Simpson and Ron Baron, counts with a liquidity position of more than $5 billion at the parent and principal subsidiaries along with nearly $10 billion drawable private fund commitments. More importantly, the company has expressed its interest into using this liquidity to make acquisitions. Management clearly stated in its letter to shareholders:

• [By John Heinzl]

  Brookfield Infrastructure (BIP) was one of six stocks I discussed in a recent column about companies that are poised to raise their dividends. Unlike the others, however, BIP isn't a corporation, but a limited partnership, and its distributions��hey aren't technically dividends��re treated differently for tax purposes.

Top 10 International Stocks To Buy For 2014: Shionogi & Co Ltd (SGIOF.PK)

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company. It is engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The Company mainly provides vitamin preparations, analgesic antipyretics, eye care products, cold and sinus medicine, digestive medicine, dermatologic preparations, antiphlogistic analgetics, antihypercholesterolemic agents, test paper for glucose in urine and artificial teeth-related products. As of March 31, 2013, the Company had 32 consolidated subsidiaries and six associated companies. Advisors' Opinion:

• [By Jason Melehani]

  ViiV Healthcare, a collaborative HIV focused venture established by GlaxoSmithKline (GSK), Pfizer (PFE) and Shionogi & Co (SGIOF.PK), is seeking approval from the FDA and the European Union for dolutegravir, an integrase inhibitor used for the treatment of HIV. Integrase inhibitors act by preventing the reverse transcribed viral DNA from integrating into the human T cell DNA.

Top 10 International Stocks To Buy For 2014: Pengrowth Energy Corp (PGH)

Pengrowth Energy Corporation (Pengrowth) is engaged in the development, production and acquisition of, and the exploration for, oil and natural gas reserves in the provinces of Alberta, British Columbia, Saskatchewan, Ontario and Nova Scotia. The Company�� producing properties include Lindbergh, Swan Hills Area, Greater Olds/Garrington Area and Southeast Saskatchewan. In February 2012, the Company commenced the injection of steam at its Lindbergh pilot project. On May 31, 2012, the Company acquired NAL Energy Corporation. In November 2012, the Company acquired additional Lochend Cardium assets with production capability of approximately 650 barrels of oil equivalent, weighted 95% to light oil. In March 2013, the Company completed the divestiture of its non-core Weyburn asset. Advisors' Opinion:

• [By Selena Maranjian]

  Finally, Graham Capital's biggest closed positions included Hess�and calls on the SPDR S&P 500 ETF. Other closed positions of interest include Halcon Resources (NYSE: HK  ) and Pengrowth Energy (NYSE: PGH  ) . Oil and gas company Halcon, operating in the promising Bakken region, as well as Texas' productive Eagle Ford shale region, among others, posted 2012 net daily production 128% higher than year-earlier levels, and proven reserves up 417%. The stock was punished after a disappointing earnings result last month, despite surging revenue. Free cash flow has moved into the red, though.

• [By Stephan Dube]

  Cold Lake's most notable producers:

  Husky Energy (HUSK.PK), see article here.Pengrowth Energy Corporation (PGH), see article here.Southern Pacific Resource (STPJF.PK), see article here.Canadian Natural Resources (CNQ), see article here.Devon Energy (DVN), see article here.Imperial Oil (IMO), see article here.Baytex, see article here.Bonavista Energy (BNPUF.PK), see article here.

  Athabasca's most notable producers:

• [By Alex Planes]

  Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price growth. Does Pengrowth Energy (NYSE: PGH  ) fit the bill? Let's take a look at what its recent results tell us about its potential for future gains.

Top 10 International Stocks To Buy For 2014: WisdomTree International Dividend Ex Financial Fund (DOO)

WisdomTree International Dividend Top 100 Fund (The Fund) is a non-diversified fund. It seeks investment results that closely correspond to the price and yield performance, before fees and expenses, of the WisdomTree International Dividend Top 100 Index (The Index). The fund is managed by WisdomTree Asset Management, Inc.

The Index measures the performance of the 100 highest dividend-yielding companies in the WisdomTree International LargeCap Dividend Index. The Index is created by selecting the top 100 companies ranked by highest dividend yield from the WisdomTree International LargeCap Dividend Index.

Advisors' Opinion:

• [By Eric Lam]

  ��ompanies that come to market are coming from sectors that work,��said Brian Huen, managing partner at Red Sky Capital Management Ltd. in Toronto. He helps manage C$220 million with the firm, and participated in the offerings for Choice Properties, Information Services Corp., and Ski-Doo maker BRP Inc. (DOO) ��eople certainly aren�� bringing any gold IPOs to market. So investors are focusing on buying deals in the right markets, as opposed to the wider market which has exposure to resources.��

Top 10 International Stocks To Buy For 2014: Adamis Pharmaceuticals Corp (ADMP)

Adamis Pharmaceuticals Corporation (Adamis), formerly Cellegy Pharmaceuticals, Inc., incorporated on April 22, 2004, operates through its wholly owned subsidiaries Cellegy Holdings, Inc., Adamis Corporation and Biosyn, Inc. Adamis Corporation has two wholly owned subsidiaries: Adamis Viral Therapies, Inc. (Adamis Viral) and Adamis Laboratories, Inc. (Adamis Labs). Adamis Labs is a specialty pharmaceutical company. The Company focuses on the development of preventive and therapeutic vaccine products and cancer drugs for patients with unmet medical needs. Adamis focuses on developing and commercializing products in the anti-inflammatory, allergy and respiratory field that are commercialized by the Company. Additional product candidates in its allergy and respiratory product pipeline include a steroid HFA (hydrofluoroalkane) metered dose inhaler product, referred to as APC-1000, for asthma and chronic obstructive pulmonary disease (COPD); a generic High-functioning autism (HFA) bronchodilator, referred to as APC-2000; and an HFA pressurized metered dose nasal steroid for the treatment of seasonal and perennial allergic rhinitis, referred to as APC-3000.

Adamis Labs��product pipeline includes the single dose-epinephrine PFS syringe product and an inhaled nasal steroid product candidate, and additional asthma and allergy products. Adamis Labs is developing an aerosolized inhaled nasal steroid product, which it referred to as APC-3000, for the treatment of seasonal and perennial allergic rhinitis. The Company�� Adamis Viral subsidiary is focused on the development of Adamis��therapeutic vaccine product candidates and prostate cancer drugs for prostate cancer patients.

Drug Product Candidates in Development

APC-100 is an anti-inflammatory drug candidate. In animal studies, APC-100 demonstrated potent anti-androgenic and anti-inflammatory activities against prostate tumors growing in animal models and showed a safety profile in preclinical safety studies. APC-100! has demonstrated pharmacological characteristics as an oral or injectable anti-inflammatory and anti-androgenic drug candidate with multiple mechanisms of action. APC-100 decreases secretion of human Prostate Specific Antigen (PSA), by human prostate cancer cells growing in mice and also increases the time-to-tumor progression and survival of PCa mice with CS-PCa and CR-PCa tumors.

APC-200 is a drug candidate for both castrate-sensitive and castrate resistant prostate cancer. APC-200 blocks androgen-induced hydrogen peroxide production and inflammation and inhibits mouse PCa. In animal studies, APC-200 was an inhibitor of chronic inflammation, also completely inhibiting oxidase mediated high rates of hydrogen peroxide. APC-200 is developed as an oral drug, specifically in appropriate formulations for patients with PCa.

APC-300 is a multi-targeted small molecule therapeutic drug, which demonstrates anti-inflammatory, pro-apoptotic anti-cancer activities for prostate cancer patients, including men with metastatic CR-PCa. In pre-clinical in vivo studies conducted, APC-300 demonstrated the ability to inhibit human tumor growth and kill both castrate-sensitive and castrate-resistant human prostate cancer tumors. It also decreased human tumor volumes and suppressed local metastasis in human xenograft models, where malignant human prostate or human melanoma tumor tissue was grafted onto athymic immunosuppressed experimental mice. APC-300 inhibited human androgen receptor protein production in these studies. It also inhibited PSA secretion by human PCa cells, which is a serum marker for human prostate cancer.

The Company competes with Medivation, TEVA Pharmaceutical Industries Ltd and AstraZeneca.

Advisors' Opinion:

• [By Bryan Murphy]

  Although the market seems to be losing traction, and even losing ground now, the same can't be said of every single stock. A handful of stocks like China Jo-Jo Drugstores Inc. (NASDAQ:CJJD), Vuzix Corp. (OTCBB:VUZI), and Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) are forging ahead, doling out gains against the grain. Not that moving higher while other names are moving lower is a sure sign that ADMP, VUZI, and CJJD will remain in their uptrends indefinitely, but it sure doesn't hurt their odds. Here's a closer look at each one and why you'd want to add them to your watchlist.

Top 10 International Stocks To Buy For 2014: Jacksonville Bancorp Inc. (JXSB)

Jacksonville Bancorp, Inc. operates as the holding company for Jacksonville Savings Bank that provides various banking products and services in Illinois. Its deposit products include interest-bearing and non interest-bearing checking accounts, savings accounts, money market accounts, term certificate accounts, individual retirement accounts, and certificates of deposit. The company?s loan portfolio comprises one-to four-family mortgage loans; commercial and agricultural real estate, and multi-family residential real estate loans; commercial and agricultural business loans; and consumer loans, such as home equity loans and lines of credit, and automobile loans. It operates through its main office, as well as through six branches located in Jacksonville, Virden, Litchfield, Chapin, and Concord, Illinois. The company was founded in 1916 and is based in Jacksonville, Illinois. Jacksonville Bancorp, Inc. is a subsidiary of Jacksonville Bancorp, MHC.

Advisors' Opinion:

• [By Traders Reserve]

  Jacksonville Bancorp (JXSB), based in Illinois, owns a loan portfolio comprised of one-to four-family residential real estate; commercial and agricultural real estate; multi-family residential real estate loans; commercial and agricultural business loans; home equity loans and lines of credit.